Overview The UT Dallas Proposal Resubmission Enhancement Program (PREP) is an internal funding mechanism designed to assist faculty who have received positive reviews of their grant application from federal agencies and are close to the pay line but are not yet funded. PREP is intended to provide funds to address limitations or issues identified by …read more
This Lab to Launch session by Bryan Chambers titled, “Early Stage Deal Structures,” is a crash course on the most common investment structures used by founders and startups to raise angel and venture capital. Bryan Chambers, Adjunct Professor in Entrepreneurship, JSOM-UTD, and VP of Accelerator and Investment Fund, Capital Factory, will host this second season …read more
Onboard with the #UTDResearch Institutional Review Board as they introduce the new online submission portal. Cayuse IRB is an online submission portal that will manage IRB protocols from initial submission to closeout. Please watch as the IRB Team walks UT Dallas Principal Investigators, Faculty Sponsors, Students, and Study Personnel through the Cayuse platform.
This Lab to Launch session by Bryan Chambers titled, “Venture Capital Fundraising” discusses various fundraising strategies and funding opportunities for transitioning from the lab to a startup. Bryan Chambers is VP of Capital Factory’s Accelerator and a General Partner in the Capital Factory’s VC fund, the most active VC fund in Texas. Prior to joining …read more
The Center Stage Seminar Series events showcase the brilliant research taking place at The University of Texas at Dallas Centers. As Dr. Jey Veerasamy took center stage in the spotlight, he showcased the Center for Computer Science Education and Outreach at UT Dallas. As the center director, Dr. Veerasamy offers coding camps and afterschool clubs …read more
“A highly selective MNK1/MNK2 inhibitor rescues core deficits associated with Fragile X Syndrome” by Tarjani Shukla, a Ph.D. candidate in Molecular and Cell Biology at the University of Texas at Dallas. Abstract: The behavioral deficits associated with Fragile X syndrome (FXS) are driven by molecular mechanisms that remain largely unknown. We hypothesize that precise control …read more
“Chronic IL-1 Exposure Promotes Prostate Cancer Androgen Receptor Independence” by Dr. Nikki Delk Abstract: Chronic inflammation drives cancer progression. We find that chronic exposure to the inflammatory cytokine, interleukin-1 (IL-1) reduces prostate cancer cell dependence on the therapeutic target, androgen receptor (AR). Thus, IL-1 chronic inflammation renders prostate cancer cells treatment-resistant. Dr. Nikki Delk, is …read more
Juan Pablo Vizuet, a PhD candidate in Chemistry at the University of Texas at Dallas, presents his research titled, “Metal-Organic Frameworks for cancer therapy.” Abstract: Metal-Organic Frameworks or MOFs are hybrid materials containing both organic and inorganic components. My research focuses on the synthesis of MOFs that contain Holmium as the metal component, an element …read more
Bringing science, technology, engineering, and math to middle and high school students is an overarching goal for BEST and a unique outreach opportunity for The University of Texas at Dallas.
Dr. Ronald Smaldone is an Associate Professor of Chemistry with a research interest in nanoporous polymers. Along with Co-PIs Dr. Mihaela Stefan and Dr. Jeremiah Gassensmith, the team received a grant to host a workshop of a team of scientists from UT Dallas, and other prestigious universities, to discuss major problems and potential solutions in …read more